( 86-755 ) 33196076 DIFFERENCES Rexiba is a specialist consulting service company focusing on helping small and medium-sized pharmaceutical corporations and bio-tech companies in Europe and North America to develop its business in China by evaluating and choosing potential products for out-licensing in China. At meantime helping Chinese DDS Company and specialty Pharmaceutical corporation to out-license technology and products in Europe and North America. Different from other consulting firms, Rexiba takes its initiative and at its own cost and expenses to make the project feasibility evaluation for China market selected from its foreign clients products portfolio  and pipeline projects in order to avoid registration risk and choose market potential project for China. Additionally Rexiba takes its initiative and at its own cost to seek and visit prospects in order to identify competent and reliable licensee, negotiating the business till completion of the agreement on behalf of its foreign clients. In addition Rexiba takes its initiative and at its own cost to seek and visit prospects in order to qualify reliable licensee competent for marketing the selected product in future, proposing term sheet and negotiating the contract till completion of the agreement signature on behalf of its foreign clients. After the agreement signature, Rexiba will at its own cost and expenses supervise the product registration in SFDA till the import license approval. Once the product is launched in China Rexiba will permanently supervise the marketing and sales of the product in China and follow up the sales forecast and firm orders during life time of product. In summary Rexiba operates as your business development office in China responsible for business development of new projects and customers service during life time of the product in China. Rexiba will invest on product selection and partner selection for you at beginning but will benefit by commission during life time of product from its business result in China brought to its foreign clients.